Skip to main content


Weitere Artikel dieser Ausgabe durch Wischen aufrufen

03.11.2017 | short review | Ausgabe 4/2017 Open Access

memo - Magazine of European Medical Oncology 4/2017

Next generation sequencing: clinical applications in solid tumours

memo - Magazine of European Medical Oncology > Ausgabe 4/2017
Dr. Leonhard Müllauer


Next generation sequencing (NGS) has unravelled the genetic alterations that underlie the pathogenesis of cancer. It is now becoming integrated into routine clinical diagnostics of malignant tumours. NGS supports diagnosis, identifies therapeutic targets, reveals resistance mechanisms and facilitates disease monitoring. It takes a central function in the implementation of cancer therapies adapted to the molecular alterations of tumours.
Über diesen Artikel

Weitere Artikel der Ausgabe 4/2017

memo - Magazine of European Medical Oncology 4/2017Zur Ausgabe